Shorter disease duration is important for tocilizumab to achieve Boolean remission. (Q44239538)
Jump to navigation
Jump to search
scientific article published on 5 February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Shorter disease duration is important for tocilizumab to achieve Boolean remission. |
scientific article published on 5 February 2013 |
Statements
Shorter disease duration is important for tocilizumab to achieve Boolean remission (English)
Yoshiko Kawasaki
Teppei Hashimoto
Yoshitada Sakai
Takashi Yamane
Kazuko Shiozawa
Shunichi Shiozawa
Akira Hashiramoto
5 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference